Stay updated on INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial page.

Latest updates to the INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial page
- Check11 days agoChange DetectedNo significant additions or deletions were detected; the content remains focused on the study overview, eligibility criteria, and plan.SummaryDifference0.4%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedSignificant: added a government operating status notice and funding caveat; updated to v3.2.0. Moderate: removed several disease entries (Small cell lung carcinoma, Cutaneous neuroendocrine carcinoma, Carcinoma of esophagus) which narrows the content. Minor: removed old version tag v3.1.0.SummaryDifference4%

- Check46 days agoChange DetectedDifference0.9%

- Check61 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed. There are no other visible changes to core content, pricing, or availability.SummaryDifference0.2%

- Check68 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%

- Check75 days agoChange DetectedThe web page has been updated to include a broader range of cancer-related resources and information, while removing some previous content related to specific cancer types and treatments. Notably, the facility name and location details have been added, enhancing the page's relevance.SummaryDifference15%

Stay in the know with updates to INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial page.